Yuejun Luo

机构：Capital Medical University, Peking University, Beijing Jishuitan Hospital, National Center for Mathematics and Interdisciplinary Sciences, Beijing Institute of Neurosurgery

发表论文 34 篇 · 总被引 874 次 · h-index 13

代表论文

The potential role of N7-methylguanosine (m7G) in cancer (2022 · Journal of Hematology & Oncology · 被引 258)
m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer (2021 · Journal of Hematology & Oncology · 被引 83)
m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer (2021 · BMC Medicine · 被引 42)
Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China (2021 · Journal of Cancer Research and Clinical Oncology · 被引 35)
RNA N 6 ‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential (2021 · Clinical and Translational Medicine · 被引 34)
An individualized immune signature of pretreatment biopsies predicts pathological complete response to neoadjuvant chemoradiotherapy and outcomes in patients with esophageal squamous cell carcinoma (2020 · Signal Transduction and Targeted Therapy · 被引 28)